News and Comments


Prohost Biotech - Monday, July 29, 2013

Elan is Taken over by Perrigo in a transaction that involves cash and shares of Perrigo.  For the details of the transaction, the press release and the PDF presentation by the New Perrigo Prohost subscribers can click on TODAY'S HIGHLIGHTS at this Website. 

This transaction was predictable. Congratulation for Prohost subscribers who kept the stock even during the time when the stock had tumbled under tremendous pressure by the market evaluators.  

FORWARD-LOOKING: Material presented here is for informational purposes only. Nothing in this article should be taken as a solicitation to purchase or sell securities. Before buying or selling any stock you should do your own research and reach your own conclusion. Further, these are our 'opinions' and we may be wrong. We may have positions in securities mentioned in this article. You should take this into consideration before acting on any advice given in this article. If this makes you uncomfortable, then do not listen to our thoughts and opinions. The contents of this article do not take into consideration your individual investment objectives so consult with your own financial adviser before making an investment decision. Investing includes certain risks including loss of principal.

Post has no comments.
Post a Comment

Captcha Image

Trackback Link
Post has no trackbacks.

Recent Postings



Merck (MRK) Velcade (bortezomib) Alder Biopharmaceuticals (ALDR) Pluristem (PSTI) Rapamune VANDA (VNDA) Auspex (ASPX) NEKTAR (NKTR)) Valeant Pharmaceuticals International (VRX) INNOVIVA (INVA) AstraZeneca (AZN) MODERNA Inovio (INO) Micromet (MITI) Ionis (IONS) Array Pharmaceuticals (ARRY) REGULUS (RGLS) Prosensa (RNA) Intrexon (XON) Intermune (ITMN) Spike Therapeutics (ONCE) Onyx (ONXX) Bristol-Myers Squibb (BMY) Human Genome Sciences (HGSI) ARCA (ABIO) TOKAI (TKAOI) SUNESIS PHARMACEUTICALS (SNSS) Elan (ELN) Alnylam (ALNY) Human Longevity (HLI) Sanofi (SNA) NOVOCURE (NVCR) KERYX (KERX) ISIS (ISIS) Agenus (AGEN Vitae Pharmaceuticals (VTAE) Bellicum (BLCM) Incyte (INCY) Theravance Bio Pharma (TBPH) SYNTA (SNTA) Benlysta (belimumab) Sangamo (SGMO) Roche (ROCHE) Biogen Idec (BIIB) Xoma (XOMA) Amgen (AMGN) CompuGen (CGEN) Advaxis (ADXS) Dynavax (DVAX) ARGOS (ARGS) Anadys (ANDS) PORTOLA (PTLA) Genentech ACADIA (ACAD) Vertex (VRTX) Sanofi-Aventis (SAN) Cytokinetics (CYTK) Multiple Myeloma GUARDIAN HEALTH CRISPR Therapeutics (CRSP) GlaxoSmithKline (GSK) Theravance (THRX) Editas (EDIT) Prolor Biotech (PBTH) SERES THERAPEUTICS (MCRB) HALOZYME (HALO) Seattle Genetics (SGEN) Sarepta (SRPT) Ocular Therapeutix (OCUL) Illumina (ILMN) Aimmune Therapeutics (AIMT) PTC Therapeutics (PTCT) Telaprevir Endometrial Cancer Roche (RHHBY) C4 Therapeutics ADVENTRIX (ANX) CEMPRA (CEMP) ZALTRAP™ AGOS (ARGS) Biocryst (BCRX) Ridaforolimus Ariad (ARIA) RenenxBio (RGNX) Exelixis (EXEL) KITE (KITE) Revlimid (lenolidamide) ImmunoGen (IMGN) IDERA (IDRA) Adaptimmune (ADAP) Abbott Laboratories (ABT) Sanofi (SNY) Agenus (AGEN) AERIE PHARMACEUTICALS NANTKWEST (NK) Gilead (GILD) Global Cell Therapeutics (GBT) Herceptin Ziofpharm (ZIOP) Anacor (ANAC) Regeneron (REGN) Dendreon (DNDN) OSI (OSIP) Tysabri Trastuzumab-DM1 Galena (GALE) Intercept (ICPT) Sequenom (SQNM) ABBVIE (ABBV) JUNO (JUNO) BIOMARIN (BMRN) JOUNCE THERAPEUTICS (JNCE) Mirati Therapeutics (MRTX) Idenix (IDIX) galapagos (GLPG) Jazz Pharmaceuticals (JAZZ) Zerenex